239 related articles for article (PubMed ID: 23469007)
1. InterAKTions with FKBPs--mutational and pharmacological exploration.
Fabian AK; März A; Neimanis S; Biondi RM; Kozany C; Hausch F
PLoS One; 2013; 8(2):e57508. PubMed ID: 23469007
[TBL] [Abstract][Full Text] [Related]
2. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
3. FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP.
Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S
Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840
[TBL] [Abstract][Full Text] [Related]
4. USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.
Luo K; Li Y; Yin Y; Li L; Wu C; Chen Y; Nowsheen S; Hu Q; Zhang L; Lou Z; Yuan J
EMBO J; 2017 May; 36(10):1434-1446. PubMed ID: 28363942
[TBL] [Abstract][Full Text] [Related]
5. Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue.
Schäfer SC; Voll AM; Bracher A; Ley SV; Hausch F
Bioorg Med Chem Lett; 2024 May; 104():129728. PubMed ID: 38582133
[TBL] [Abstract][Full Text] [Related]
6. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.
Sinars CR; Cheung-Flynn J; Rimerman RA; Scammell JG; Smith DF; Clardy J
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):868-73. PubMed ID: 12538866
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
8. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Pei H; Li L; Fridley BL; Jenkins GD; Kalari KR; Lingle W; Petersen G; Lou Z; Wang L
Cancer Cell; 2009 Sep; 16(3):259-66. PubMed ID: 19732725
[TBL] [Abstract][Full Text] [Related]
9. The Many Faces of FKBP51.
Hähle A; Merz S; Meyners C; Hausch F
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669684
[TBL] [Abstract][Full Text] [Related]
10. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
[TBL] [Abstract][Full Text] [Related]
11. Large FK506-binding proteins shape the pharmacology of rapamycin.
März AM; Fabian AK; Kozany C; Bracher A; Hausch F
Mol Cell Biol; 2013 Apr; 33(7):1357-67. PubMed ID: 23358420
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications and stress adaptation: the paradigm of FKBP51.
Rein T
Biochem Soc Trans; 2020 Apr; 48(2):441-449. PubMed ID: 32318709
[TBL] [Abstract][Full Text] [Related]
13. FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.
Stechschulte LA; Hinds TD; Ghanem SS; Shou W; Najjar SM; Sanchez ER
Mol Endocrinol; 2014 Aug; 28(8):1254-64. PubMed ID: 24933248
[TBL] [Abstract][Full Text] [Related]
14. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
[TBL] [Abstract][Full Text] [Related]
15. The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.
Park JM; Yang SW; Zhuang W; Bera AK; Liu Y; Gurbani D; von Hoyningen-Huene SJ; Sakurada SM; Gan H; Pruett-Miller SM; Westover KD; Potts MB
PLoS Biol; 2021 Jun; 19(6):e3001281. PubMed ID: 34077419
[TBL] [Abstract][Full Text] [Related]
16. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats.
Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496
[TBL] [Abstract][Full Text] [Related]
17. FKBP51 regulates decidualization through Ser473 dephosphorylation of AKT.
Wei M; Gao Y; Lu B; Jiao Y; Liu X; Cui B; Hu S; Sun L; Mao S; Dong J; Yan L; Chen Z; Zhao Y
Reproduction; 2018 Mar; 155(3):283-295. PubMed ID: 29363568
[TBL] [Abstract][Full Text] [Related]
18. FKBP51 and FKBP12.6-Novel and tight interactors of Glomulin.
Hähle A; Geiger TM; Merz S; Meyners C; Tianqi M; Kolos J; Hausch F
PLoS One; 2019; 14(9):e0221926. PubMed ID: 31490997
[TBL] [Abstract][Full Text] [Related]
19. The prospect of FKBP51 as a drug target.
Schmidt MV; Paez-Pereda M; Holsboer F; Hausch F
ChemMedChem; 2012 Aug; 7(8):1351-9. PubMed ID: 22581765
[TBL] [Abstract][Full Text] [Related]
20. C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90.
Cheung-Flynn J; Roberts PJ; Riggs DL; Smith DF
J Biol Chem; 2003 May; 278(19):17388-94. PubMed ID: 12611898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
